Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-25

Clinical Trial Update: Vitamin E Supplementation in Hyperinsulinism/Hyperammonemia Syndrome [NA]

View source ↗

Summary

A completed clinical trial investigating vitamin E supplementation in Hyperinsulinism-Hyperammonemia Syndrome; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin E supplementation (vitamin E)

Snippet

Sponsor: Elizabeth A Rosenfeld | Conditions: Hyperinsulinism-Hyperammonemia Syndrome | NA | Status: COMPLETED | Results posted: 2022-11-25